Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pairaudeau

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Physician office readiness for managing Internet security threatsK Keshavjee, N Pairaudeau, A Bhanji
Obstetrics and Gynecology|April 1, 1976
Prolactin hypersecretion and short luteal phase defectsB Corenblum, N Pairaudeau, A B Shewchuk
Journal of Clinical Pharmacology|June 27, 2000
Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionalsM Pole, A Einarson, N Pairaudeau, et al.
American Journal of Obstetrics and Gynecology|March 1, 1980
Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromesA B Shewchuk, B Corenblum, N Pairaudeau, et al.
American Journal of Obstetrics and Gynecology|November 1, 1977
Amniotic fluid testosterone in the prenatal determination of fetal sexB B Pirani, N Pairaudeau, T A Doran, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Physician office readiness for managing Internet security threatsK Keshavjee, N Pairaudeau, A Bhanji
Obstetrics and Gynecology|April 1, 1976
Prolactin hypersecretion and short luteal phase defectsB Corenblum, N Pairaudeau, A B Shewchuk
Journal of Clinical Pharmacology|June 27, 2000
Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionalsM Pole, A Einarson, N Pairaudeau, et al.
American Journal of Obstetrics and Gynecology|March 1, 1980
Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromesA B Shewchuk, B Corenblum, N Pairaudeau, et al.
American Journal of Obstetrics and Gynecology|November 1, 1977
Amniotic fluid testosterone in the prenatal determination of fetal sexB B Pirani, N Pairaudeau, T A Doran, et al.
Pageof 1